Androgen deprivation therapy and competing risks

JAMA. 2011 Dec 7;306(21):2382-3. doi: 10.1001/jama.2011.1791.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Cardiovascular Diseases / mortality*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality*
  • Randomized Controlled Trials as Topic*

Substances

  • Androgen Antagonists